Transcription from the HIV-1 long terminal repeat (LTR) is mediated by numerous host transcription factors. In this study we characterized an E-box motif (RBE1) within the core promoter that was previously implicated in both transcriptional activation and repression. We show that RBE1 is a binding site for the RBF-2 transcription factor complex (USF1, USF2, and TFII-I), previously shown to bind an upstream viral element, RBE3. The RBE1 and RBE3 elements formed complexes of identical mobility and protein constituents in gel shift assays, both with Jurkat T-cell nuclear extracts and recombinant USF/TFII-I. Furthermore, both elements are regulators of HIV-1 expression; mutations in LTR-luciferase reporters and in HIV-1 molecular clones resulted in decreased transcription, virion production, and proviral expression in infected cells. Collectively, our data indicate that RBE1 is a bona fide RBF-2 binding site and that the RBE1 and RBE3 elements are necessary for mediating proper transcription from the HIV-1 LTR.
Introduction
HIV-1 gene expression is driven by the long terminal repeat (LTR) which functions as the viral promoter. Transcription from the LTR is dependent on host cell machinery and, as such, the viral LTR contains numerous cis-elements that bind host cell transcription factors (Reviewed in Coiras et al., 2009; Colin and Van Lint, 2009; Pereira et al., 2000; Sadowski et al., 2008) . As the availability and function of transcription factors are subject to regulation by cellular differentiation and activation state, HIV-1 gene expression and replication are tightly linked to the host cell's activation state (Sadowski and Mitchell, 2005) . In CD4+ T-lymphocytes, which are one of the main cell populations producing HIV-1 in vivo, viral transcription is controlled by three main signalling pathways and their cognate downstream effectors, including the Ras/MAPK/AP1/Ets (GABP), the PKCθ-IKK/NF-κB, and the NFAT/calcineurin pathways. Moreover, numerous other transcription factors bind the LTR in the basal or activated states to modulate gene expression (Pereira et al., 2000) .
In addition to AP1, Ets/GABP, and NF-κB, the induction of HIV-1 by the Ras/MAPK pathway downstream of the T-cell receptor is mediated by Ras-responsive-binding-factor 2 [RBF-2, Chen et al., 2005; Malcolm et al., 2007; Malcolm et al., 2008) ]. RBF-2 is a multi-component complex composed of the basic-helix-loop-helixleucine zipper (bHLH-ZIP) upstream stimulatory factor (USF) proteins USF1 and USF2 and the multi-functional factor TFII-I (Chen et al., 2005; Estable et al., 1999; Malcolm et al., 2007) . The ubiquitously expressed USF proteins are known to bind canonical E-box elements (CANNTG) as a USF1/USF2 heterodimer (Sirito et al., 1994) ; however, we have previously shown that USF1/2, together with TFII-I, binds a highlyconserved, atypical site in the HIV-1 U3 enhancer region (ACTGCTGA), 120 nucleotides upstream from the transcriptional start site, termed Ras-responsive-binding-element 3 [RBE3, Estable et al., 1996; Estable et al., 1998; Malcolm et al., 2008) ]. Moreover, binding of USF to RBE3 shows a requirement for TFII-I as, in its absence, RBE3 is a low affinity USF binding site in vitro (Chen et al., 2005; Malcolm et al., 2007 Malcolm et al., , 2008 . Functionally, both the viral RBE3 element and the host RBF-2 factor are essential for the transcription of chromosomally-integrated HIV-1 in response to T-cell activation by T-cell receptor engagement or phorbol-12-myristate-13-acetate Virology 418 (2011) 57-66 (PMA) treatment (Chen et al., 2005; Malcolm et al., 2007 Malcolm et al., , 2008 . In addition, integrated LTR reporters with a mutant RBE3 (mRBE3) element show reproducible two-fold increases in basal level expression relative to wild type, suggesting that RBF-2 may bind to the latent, uninduced LTR and contribute to its repression (Chen et al., 2005; Malcolm et al., 2008) . Indeed, TFII-I has been shown to function as a repressor by directly interacting with HDAC3 at the c-fos and Vβ promoters (Wen et al., 2003) .
Previous studies have implicated an additional E-box element (CAGCTG, − 21 to − 16), between the TATA box and initiator element of the U3 core promoter, in regulation of HIV-1. This element, also known as the 3′ E-box, is capable of binding the CAGCTG-specific, bHLH-ZIP transcription factor, Activating Protein 4 (AP4) (Hu et al., 1990; Mermod et al., 1988; Ou et al., 1994) . In the context of HIV-1, overexpression of AP4 in HEK 293T cells appears to cause repression of LTR-driven transcription through multiple mechanisms: 1) AP4 bound to the 3′ E-box can antagonize the binding of TATA binding protein (TBP) in vitro, and 2) AP4 can mediate the recruitment of HDAC1 to the LTR in vivo (Imai and Okamoto, 2006; Ou et al., 1994) . Additionally, our group implicated this 3′ E-box element, as well as the RBE3 sequence, in mediating the response to v-Ras activated LTR expression and termed the site Rasresponsive-binding-element-1 [RBE1, ]. Indirect evidence suggested that RBE1 and RBE3 may bind the same factor, RBF-2, however this possibility was never tested directly .
Given the sequence similarity between the viral cis-acting elements RBE1 and RBE3 (core GCTG motif) and the ability of both to positively mediate the response of the LTR to v-H-Ras , we hypothesized that the transcription factor complex RBF-2 binds to both RBE1 and RBE3. In this study, we analyzed RBE1-bound complexes formed with T-cell nuclear extracts as well as recombinant proteins, and found that the complex formed at RBE1 contained the RBF-2 components USF1, USF2 and TFII-I. This sequence was capable of competing for RBF-2 bound to RBE3 in electrophoretic mobility shift assays (EMSA), and formed a complex of identical mobility as RBF-2 bound to RBE3. We also examined the effect of mutant RBE elements on transcription from the HIV-1 LTR. RBE1 and RBE3 mutants exhibited a modest but reproducible decrease in reporter gene activity while the RBE1/3 double mutant LTR displayed an additive reduction in activity. These observations were extended to virion production experiments and reporter cell infections using full-length HIV-1 molecular clones, which were consistent with findings from the transient LTR-reporter assays. Collectively, our results indicate that RBE1 is a novel binding site for the transcription factor complex RBF-2 (USF1/2 and TFII-I). Furthermore, our data suggests that the highly conserved RBE1 and RBE3 elements flanking the HIV-1 enhancer contribute to controlling proper expression of viral gene products in infected cells.
Results
Proteins in Jurkat T-cell nuclear extracts form complexes of identical mobility at both RBE3 and RBE1 sites Given the similarity between the RBE1 and RBE3 sequences (core GCTG motif, Fig. 1 ), we examined complexes bound to this region of the LTR in Jurkat T-cells. We compared protein-DNA complexes formed with Jurkat nuclear extract at both RBE1 and RBE3 by EMSA. A labelled RBE1-containing oligonucleotide probe formed a complex of identical mobility to RBE3-bound RBF-2. Although complexes of identical mobility were formed using both probes, we noted a substantially lower gel shift intensity for RBE1 as compared to RBE3 ( Fig. 2A , compare lanes 1 and 4). Binding of these complexes to both probes could be competed by unlabeled RBE1 or RBE3 oligos ( Fig. 2A , lanes 2-3 and 5-6), suggesting that the complexes have similar sequence specificity. Additionally, we noted that the RBE1 oligonucleotide produced a slower migrating and uncharacterized complex that was previously designated the TATA binding complex [TBC, ]. The RBE3, but not the RBE1, oligonucleotide also formed a complex with another transcription factor YY1, which is consistent with previous data . These observations indicate that the regions of the LTR containing RBE1 and RBE3 both form complexes with proteins in Jurkat nuclear extract that have similar sequence specificity, in addition to other factors.
RBE1-Jurkat nuclear extract complexes contain RBF-2 and are distinct from AP4
The RBE1 cis-element spans a consensus E-box previously shown to bind AP4 (Imai and Okamoto, 2006; Ou et al., 1994) . Given the fact that at RBE1 we observed a complex with identical properties to RBF-2, we probed the identity of proteins bound to oligonucleotides spanning this region using specific antibodies. We confirmed that AP4, TFII-I, USF1, and USF2 were present in Jurkat T-cell nuclear extracts using immunoblotting (Fig. 2B) . We next performed EMSA with a radiolabelled RBE1-containing oligo and Jurkat nuclear extracts. In the absence of any competitor oligos or antibodies, we observed complexes corresponding to both RBF-2 as well as the previously described TBC complex (Fig. 2C, lane 2) . The former complex could be competed away by excess unlabelled RBE1 (Fig. 2C, lane 3) or RBE3 oligonucleotides (Fig. 2C , lane 6) but not by oligonucleotides bearing a mutation within RBE1 that, in conjunction with a mutation in RBE3, was previously shown to prevent stimulation of the LTR by v-Ha-Ras (mRBE1- Fig. 2C , lane 4) , a mutation shown to inhibit binding of AP4 (mAP4- Fig. 2C , lane 5) (Imai and Okamoto, 2006; Ou et al., 1994) , or a mutation of the RBE3 element (mRBE3- Fig. 2C , lane 7) . These results indicate that the complex formed with
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Jurkat nuclear extracts at RBE1 specifically recognizes the 3′ E-box element flanking the TATA box and likely contains RBF-2. To further examine the interaction of RBF-2 at RBE1, we added antibodies against RBF-2 constituents as well as AP4 to the EMSA reactions. Antibodies against USF1 (Fig. 2C , lane 8) and USF2 (Fig. 2C , lane 9) both prevented formation of the RBF-2 complex, whereas an antibody against TFII-I formed a supershifted species (Fig. 2C,  lane 11) . Surprisingly, antibodies against AP4 did not disrupt any of the complexes formed with the RBE1 oligonucleotide, including the RBF-2 complex; moreover, no supershifted species were observed with the AP4 antibody (Fig. 2C, lane 10) . Taken together, these results suggest that at endogenous levels of protein in Jurkat Tcell nuclear extracts, RBE1 is preferentially bound by RBF-2 rather than by AP4, and that RBE1 is a bona fide RBF-2 binding site. Recombinant USF and TFII-I bind an RBE1 containing oligonucleotide
To confirm that USF and TFII-I are capable of binding to the RBE1 element 3′ of the TATA box, we performed EMSA with recombinant USF1 and USF2 produced in baculovirus infected Sf21 insect cells. When co-expressed, USF1 and USF2 produced three complexes bound to an RBE3-containing oligonucleotide representing USF2 homodimers, USF1/USF2 heterodimers, and USF1 homodimers (Fig. 3A , lane 1). The identity of these complexes was verified by the inclusion of α-FLAG and α-USF2 antibodies, which caused a supershift of FLAGtagged USF1 (Fig. 3A , lane 5) and native USF2 (Fig. 3A, lane 6) . Binding of each of the complexes could be competed with unlabeled wild type RBE3 oligonucleotide (Fig. 3A , lane 2), but not an RBE3 mutant oligonucleotide (Fig. 3A, lane 3) . Importantly, complexes with identical mobility were observed in EMSA reactions using an RBE1-containing probe (Fig. 3A, lanes 7-12) . Binding of the USF complexes could be competed by excess unlabeled wild type RBE3 or RBE1 oligonucleotides (Fig. 3A , lanes 8 and 10), but not by mutant RBE3 oligonucleotides (Fig. 3A, lane 9) . Furthermore, complexes formed with recombinant USF on the RBE1 oligo were supershifted by the inclusion of specific antibodies (Fig. 3A , lanes 11 and 12). These findings suggest that the RBE1 E-box element immediately downstream of the TATA box is bound by recombinant USF1/2 heterodimers, consistent with the results obtained with Jurkat nuclear extracts (Fig. 2) .
TFII-I enhances the USF-RBE1 interaction in vitro
To examine the involvement of TFII-I in binding of USF to RBE1, we determined whether recombinant TFII-I was capable of stimulating binding of USF to RBE1 in an EMSA reaction, similar to the effect previously shown for binding of USF to RBE3 . We found that addition of TFII-I at an approximately 10-fold molar excess caused a 2-3-fold enhancement of USF binding (Fig. 3B , lanes 2-7). This effect is somewhat smaller than the 10-fold enhancement by TFII-I for binding of USF to the non-canonical RBE3 site . This difference is likely attributed to the fact that RBE1 contains an E-Box motif (CAGCTG), to which USF heterodimers are capable of binding on their own (Corre and Galibert, 2005) . Interestingly, recombinant TFII-I itself formed several complexes with the RBE1 probe in EMSA reactions (Fig. 3B, lane 13) , which might reflect binding of TFII-I monomers to multiple sites, or as a multimer to a single site. We have not fully characterized the DNA binding specificity for TFII-I in this region of the LTR, but we noted that a mutation within the E-box motif (CAGCTGC to CAGggtg) prevented competition for binding to USF1 and USF2, but not to the TFII-I specific complex (lane 12). This suggests that TFII-I must bind to sequences flanking the E-box. Consistent with this, it was previously demonstrated that USF and TFII-I bind cooperatively at both E-box and Inr elements within the Adenovirus major late (AdML) promoter (Roy et al., 1991) . These results, taken together with previous observations Chen et al., 2005; Malcolm et al., 2007 Malcolm et al., , 2008 , confirm that USF and TFII-I are bound together at both RBE1 and RBE3, which flank the core promoter and enhancer regions of the HIV-1 LTR.
Interaction of RBF-2 at RBE1 can be observed by DNaseI footprinting
In order to confirm that USF binds directly overlapping the E-box element spanning RBE1, we performed DNaseI footprinting analysis of recombinant RBF-2 constituents on the core HIV-1 LTR promoter region. A template of approximately 120 nucleotides, spanning the 5′ most SP1 binding site (−82) to the TAR stem loop (+ 42) was used for footprinting with recombinant USF1/2 and TFII-I expressed in baculovirus infected Sf21 insect cells. In the absence of TFII-I, USF1/2 protected a region of approximately 20 nucleotides centered over the RBE1 E-box (Fig. 4A, lanes 3 and 4) . Consistent with the EMSA results shown above, addition of TFII-I to footprinting reactions containing a minimal amount of USF1/2 caused enhanced protection of this same region of the LTR (Fig. 4A, lanes 7 and 8) . However, TFII-I alone did not produce specific protection, despite the above observation that it forms multiple complexes with the RBE1 probe in EMSA (Fig. 3B ). Similar observations were noted previously for interaction of TFII-I with the AdML initiator element (Roy et al., 1991) , and with the upstream HIV-1 RBE3 element .
Binding of USF/TFII-I to RBE1 produced a footprint larger than that of the E-box consensus sequence itself (Fig. 4A, lanes 3-8) . USF, alone or in combination with TFII-I, protected a region of approximately 20-25 nucleotides including the TATA box and the RBE1 motif, as well as approximately five nucleotides on both sides. This result is similar to footprinting assays for USF/TFII-I binding to the RBE3 element and USF to the upstream E-box (−166 to −161), where binding protects approximately 20 nucleotides centered over both elements . This may reflect natural sites of non-specific contact between USF and its cognate binding site. Indeed, it has been previously described that USF protects approximately 20 nucleotides on the AdML (Roy et al., 1991) and Human Apolipoprotein C-III promoters (Pastier et al., 2002) . Mutation of the RBE1 element . Recombinant USF1/USF2 and TFII-I (RBF-2) bind RBE1, immediately 3′ of the HIV-1 TATA box. A: EMSA reactions were performed with insect cell extracts expressing USF1-FLAG and USF2, and labelled RBE3 (lanes 1-6) or RBE1 (lanes 7-12) probes. Unlabeled competitor RBE3 (lanes 2 and 8), mutant RBE3 (lanes 3 and 9), or RBE1 (lanes 4 and 10) oligos were added at 100-fold molar excess. 2 μg α-FLAG antibody was added in lanes 5 and 11, and 2 μg of α-USF2 antibody was added to reactions in lanes 6 and 12. completely abolished protection by USF in DNaseI footprinting assays (Fig. 4B, lanes 3-8) , either alone or in combination with TFII-I. Taken together, DNaseI footprinting supports the contention that RBE1 serves as a binding site for RBF-2.
RBE elements mediate transcriptional activation in transient assays
Despite the extensive sequence diversity of HIV-1, the RBE1 and RBE3 sequences are highly conserved amongst clinical isolates, suggesting that these two elements are important for HIV-1 replication (Estable et al., 1996 (Estable et al., , 1998 (Estable et al., , 1999 Jeeninga et al., 2000; Malcolm et al., 2008) . Since USF and TFII-I have been shown to have both activating and repressive effects depending on context [promoter, cell type, and cellular activation state-reviewed in (Corre and Galibert, 2005; Roy, 2007; Yang et al., 2002) ], and the viral RBE1 and RBE3 elements are both bound by RBF-2, we sought to evaluate the role of these elements in the regulation of HIV-1 expression. In order to test the role of the RBE elements in mediating both basal transcription as well as Tatactivated transcription, we created LTR-luciferase reporter constructs bearing mutant RBE elements, both with and without the TAR stem loop. Given the stimulatory effect of Tat-transactivation when TAR is present (Berkhout et al., 1989) , we transiently transfected HEK 293T cells with the LTR-luciferase reporter constructs both in the presence and absence of the viral transactivator Tat. Fig. 5 shows that, regardless of TAR and Tat, the RBE3 and RBE1/RBE3 mutant LTRs resulted in a two-fold decrease in reporter activity compared to wild type. Additionally RBE1 mutant reporters exhibited a more modest 25% reduction in activity relative to wild type. This pattern of activity amongst the LTR reporters was consistent between all combinations of TAR and Tat tested (Fig. 5) . When TAR and Tat were both present, luciferase activity was strongly induced (approximately 15-fold increase compared to the expression level measured in the absence of Tat). Furthermore, the same relative expression pattern was apparent among wild type and mutant promoters suggesting that the RBE elements do not alter the ability of the LTR to respond to Tatmediated activation but rather regulate basal level activity (Fig. 5) . Taken together, these data confirm that intact RBE elements are required for efficient LTR transcription and therefore, may play a role in regulating HIV-1 expression. 
RBE elements are required for efficient HIV-1 virion production
In order to assess the role of the RBE elements in HIV-1 expression and production, we constructed full-length LAI molecular clones with mutations of the RBE elements in only the 3′ LTR or in both the 3′ and 5′ LTRs. As expression of the molecular clones is driven by the 5′ LTR, mutations present in the 3′ LTR will only affect LTR activity after reverse transcription and infection of target cells (Fig. 6A) . We generated wild type and mutant viral stocks by transfection of 293T cells with a low amount of DNA (50 ng) and quantified virion production in the supernatants by p24 ELISA (Fig. 6B) . As expected, we observed no difference in p24 levels between the 3′ LTR mutants and wild type (Fig. 6B, black bars) . In contrast to the 3′ LTR mutants, virion production was affected by the 5′ LTR mutants. The 5′ LTR RBE3 and RBE1 single mutants showed a 25 and 60% decrease in levels of p24, respectively, which was further reduced in the RBE1/3 double mutant (approximate five-fold reduction, Fig. 6B , white bars). These data are consistent with the results of the LTR-luciferase assays and support the idea that the RBE elements may play a role in mediating proper HIV-1 expression.
We next wanted to examine the effects of the mutant RBE elements in the context of integrated proviruses by comparing the viruses' expression in a single cycle assay using TZM-bl reporter cells. TZM-bl cells are a HeLa-derived cell line that express the HIV-1 entry receptors CD4, CXCR4 and CCR5, and contain an integrated HIV-1 promoter that drives expression of β-galactosidase in response to infection-mediated Tat expression. We transfected 293T cells with molecular clones bearing mutations in the 3′ LTR only and used virus stocks to infect TZM-bl reporter cells (Fig. 6C) . The RBE single mutants exhibited a modest but reproducible reduction in expression from the integrated provirus as compared to wild type. In contrast, the RBE1/3 double mutant exhibited a sizable, five-fold decrease in proviral expression relative to wild type (Fig. 6C) . These data are consistent with the transient promoter assay and viral expression from plasmids, suggesting that HIV-1 expression from integrated proviruses is similarly affected by the RBE mutations. However, when we compared the effects of the mutations with two different amounts of transfected DNA, we found that that the effect of the RBE1 and RBE3 mutations is more pronounced at lower levels of viral input (compare 50 ng to 100 ng inputs- Fig. 6C ).
To further examine the effects of viral input on the phenotype of the RBE mutants, we titrated wild type and 3′ LTR mutant viruses on TZM-bl cells. Consistent with the previous experiments, the single RBE3 and RBE1 mutants exhibited decreased expression, which was further decreased in the double mutant. We again observed a more pronounced decrease in infectivity for the mutants at lower inputs (Fig. 7) . Furthermore, the difference in relative infectivity of the RBE1 and the RBE3 mutants was affected by the amount of virus. Mutant RBE1 had significantly higher infectivity than mutant RBE3 at high input, but similar infectivity when less virus was used. These results are consistent with those in Fig. 6C and, taken together, suggest that the effects of the RBE mutations may be affected by concentration (DNA or virus), although the consequences of this are currently unknown. Collectively, our results indicate a role for the RBE3 and RBE1 elements in the proper regulation of HIV-1 gene expression through activation of LTR-driven transcription.
Discussion
HIV-1 exploits host cell transcription factors to regulate its initial expression from the proviral LTR. Different mechanisms ensure transcription in different cell types and cellular activation states (Pereira et al., 2000; Sadowski et al., 2008) . In activated T lymphocytes, a combination of factors responsive to T-cell signalling pathways (NF-κB, NFAT, AP1 and GABP/Ets) permits robust transcription of the provirus (Brooks et al., 2003; Robichaud et al., 2002) . Conversely, reversion to a resting memory CD4+ T-cell state results in repression of the provirus through reorganization of the LTR into repressive chromatin (Han et al., 2007; Mok and Lever, 2007) , thereby leading to post-integration molecular latency (Reviewed in Coiras et al., 2009; Colin and Van Lint, 2009; Lassen et al., 2004; Richman et al., 2009; Trono et al., 2010) . Among the elements that mediate transcriptional regulation of the HIV-1 LTR are two elements that flank the core viral enhancer, RBE1 and RBE3.
In this study, we demonstrated that the RBE1 element is a novel binding site for the transcription factor complex RBF-2. In both EMSA and DNaseI footprinting experiments, RBF-2 constituents USF1, USF2 and TFII-I bound the RBE1 E-box (Figs. 2-4) . Of note, we were unable to detect AP4 in complexes bound to RBE1 in EMSA experiments with Jurkat T-cell nuclear extracts, whereas USF1, USF2 and TFII-I did form complexes with this element as detected by specific antibodies (Fig. 2C ). We were able to detect AP4 protein expression in Jurkat nuclear extracts by immunoblotting (Fig. 2B) , and it is possible that binding of RBF-2 is mutually exclusive of AP4. Additionally, the effect of AP4 on transcription from the LTR may be modified by the signalling state of the cell, dictated by various post translational modifications, and/or be subject to regulation by other transcription factors recruited to the promoter. As such, whether or not RBF-2 is a binding partner or competitor of AP4, it may be that at endogenous levels of Jurkat T-cell nuclear protein, the effect of AP4 is masked by the action of RBF-2. Although further work will be needed to elucidate this relationship, we clearly observe that single and double mutations of RBE1 and RBE3 decrease transcription from the LTR, virion production, and proviral expression (Figs. 5 and 6) . Importantly, these effects are the opposite of what would be expected for RBE1 if a repressor protein like AP4 is the sole factor binding this site. Interestingly, binding of multiple host transcription factors to the same cis-element within the HIV-1 LTR has been observed before, most notably the duplicated NF-κB/NFAT sites (Bates et al., 2008; Cron et al., 2000; Kinoshita et al., 1997; Koken et al., 1992; Michael et al., 1994) .
Analyses of transcription, virion production and proviral expression suggest that, together, the RBE1 and RBE3 elements mediate the proper transcriptional activation of HIV-1. Given that the two elements bind the same factor in vitro, it is not surprising that these elements would have similar effects on LTR-driven transcription. However, previous work by our group using stably integrated LTR reporters in clonal cell lines has shown that RBE3 mutants exhibit a modest but reproducible increase in basal transcription, thus suggesting a dual role for RBE3 in which it can also act as a mediator of transcriptional repression (Chen et al., 2005; Malcolm et al., 2007 Malcolm et al., , 2008 . While these differences could be a result of the lack of proper chromatin environment in transient assays, we note that the results of our transient experiments were consistent with assays of proviral expression in TZM-bl cells. It is also interesting to note that the Jurkat cell lines used in our previous studies were subject to long-term passaging prior to the assessment of promoter activity. This time frame would allow the integrated retroviral reporters to be epigenetically silenced (Ellis, 2005) , and this silencing could be differentially affected by the RBE3 mutation, thus implicating RBE3 in mediating long-term transcriptional repression. Reduced silencing of the mutant RBE3 reporter could be caused by less efficient RBE3-RBF-2 mediated recruitment of silencing factors to the LTR or due to the reduced initial LTR activity prior to the establishment of silencing. In both scenarios, the overall level of silencing in the mutant LTR would be reduced relative to wild type, and the RBE3 element, along with RBF-2, would appear to mediate transcriptional repression. Further work is needed to elucidate the role of RBF-2 in mediating proviral silencing and latency as well as to reconcile the duality of function RBF-2 seems to possess.
Regardless of any involvement in epigenetic silencing, our data indicate that both the RBE1 and RBE3 elements are involved in coordinating efficient LTR activity; thus, future experiments are also needed to elucidate the precise mechanism(s) of RBE-mediated transcriptional control. Specifically, chromatin immunoprecipitation (ChIP) experiments coupled with siRNA knockdown of RBF-2 factors should allow for the elucidation of RBF-2 function at RBE1 and RBE3 in integrated, chromatin bound LTRs, both in the basal and activated states. However, the close proximity of the RBE elements (~100 bp apart), and the presence of an additional USF binding site~40 bp upstream of RBE3 (Coiras et al., 2009; Colin and Van Lint, 2009; Lassen et al., 2004; Richman et al., 2009; Trono et al., 2010) , makes it technically challenging to use ChIP and siRNA analysis to delineate between RBF-2 bound at both RBE elements. It is interesting to note however, that in RBE1 and RBE3, the HIV-1 LTR contains two highly conserved sites that bind the same factor (RBF-2). In vitro evidence suggests that the leucine zipper domain of USF is capable of forming higher-order homotetramer complexes at intracellular protein concentrations (Ferre-D'Amare et al., 1994) . While it is unclear if this interaction occurs in vivo, or how the presence of TFII-I would impact potential interactions, higher order USF structures may potentiate LTR looping interactions that could contribute to additional levels of transcriptional regulation.
Fully characterizing the function of RBF-2 at the RBE elements, as well as other HIV-1 transcriptional regulators bound to the LTR, is of considerable clinical interest since modulating their functions may produce novel therapeutic interventions that target not only replicating viruses but also latent HIV-1 proviruses. Novel approaches may allow for targeted and controlled reactivation of latent reservoirs by inhibiting transcriptional repressors and/or stimulating transcriptional activators. Conversely, it may be possible to permanently repress 
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WT mRBE3 mRBE1 mRBE1/3 Fig. 7 . Infectivity defects of mutant RBE viruses are affected by input. The integrated proviral expression of wild type and mutant RBE viruses was measured over a range of viral inputs. Viral supernatants were produced as in Fig. 6 and diluted by the given factors prior to triplicate infection of TZM-bl cells. β-galactosidase activity was measured 48 h post infection; mean values are plotted relative to the expression of the wild type virus at each dilution and error bars represent one standard deviation in TZM-bl values.
these reservoirs by stimulating repressor function in a cell type specific manner. Thus, the development of novel therapeutics to robustly modulate HIV-1 transcription would provide welcome new weapons for use in the eradication of HIV-1.
Materials and methods

Protein-DNA interaction assays
USF/TFII-I EMSAs were performed as previously described . For EMSA and DNaseI footprinting, USF1, USF2 and TFII-I were produced by expression in Sf21 insect cells from baculovirus vectors (Chen et al., 2005) . Recombinant SP1 was obtained commercially (Promega). Jurkat nuclear extracts for EMSA reactions were prepared as previously described (Li et al., 1991) . Antibodies used were as follows: AP4 (ab28512, Abcam), TFII-I (Chen et al., 2005) , USF1 (H-86, Santa Cruz), and USF2 (N-18, Santa Cruz). Proteins were detected in 10 μg of Jurkat nuclear extract by immunoblotting with the antibodies listed above (1 μg/mL, 4°C overnight). Double stranded oligos used for EMSA are listed in Table 1 P]dGTP (Perkin Elmer). Unincorporated label was removed using a Sephadex G-50 spin column (GE Healthcare) and the probe was purified using a DNA spin column (Qiagen). Binding reactions and DNaseI (Promega) digestions were performed as previously described with the indicated amounts of USF1, USF2, TFII-I, and SP1 protein and approximately 4 × 10 4 counts per minute (cpm) of labelled LTR probe. After incubating the proteins with the DNA probe for 30 min at 4°C, reactions were incubated with 1.75 units of DNaseI for 45 s at room temperature prior to the addition of 100 μl DNaseI stop solution (0.2 M NaCl, 20 mM EDTA, 1% SDS, 200 μg/mL proteinase K), and incubation at 55°C for 1 h. Following extraction with phenol/chloroform and ethanol precipitation, radioactivity in the pellets was measured in a Beckman LS 3801 scintillation counter. Samples were re-suspended in sequencing loading buffer (0.2 mg/mL bromophenol blue and xylene cyanol, 25 mM EDTA, 90% deionized formamide), denatured at 100°C for 2 min, and approximately 2.5 × 10 4 cpm were analyzed per lane on an 8% polyacrylamide-urea gel alongside a G + A sequencing ladder produced as previously described (Bencini et al., 1984) .
Cell culture
Transformed cell lines: Jurkat T-cells as well as the TZM-bl reporter cells were obtained from the National Institutes of Health (NIH) AIDS Reagent Program (Derdeyn et al., 2000; Platt et al., 1998; Smith et al., 1984; Takeuchi et al., 2008; Wei et al., 2002; Weiss et al., 1984) . Human embryonic kidney (HEK) 293T and Sf21 insect cells were obtained from the American Type Culture Collection. Jurkat cells were grown in RPMI 1640 (Sigma) plus 10% fetal bovine serum (Sigma) supplemented with penicillin (100 U/mL) and streptomycin (100 mg/mL) (Gibco), and maintained in a humidified 37°C, 5% CO 2 atmosphere. HEK 293T and TZM-bl cells were grown under standard conditions as previously described (Harari et al., 2009 ). Sf21 insect cells were grown in Sf-900 II insect media (Gibco) plus 10% fetal bovine serum and maintained at 27°C.
Transient luciferase expression assays
To measure promoter activity, the 3′ LTR from the molecular clone LAI was cloned either with or without the TAR stem loop into the promoter-less reporter vector pGL3-Basic (Promega). To create reporters with TAR, the 3′ LTR was PCR amplified with oligos oMD099 and oMD102 (Table 2 ) from LAI molecular clones and inserted into the KpnI/HindIII sites of pGL3-Basic to create pGL3TAR-WT, pGL3TAR-mRBE3, pGL3TAR-mRBE1, and pGL3TAR-mRBE1/3. To create the identical reporters without TAR, the amplified LTR was instead cloned into the KpnI/SacI sites of pGL3-Basic. The LTR-luciferase reporter constructs used are summarized in Table 3 . For transient assays, 10 ng of the pGL3 reporter plasmid along with 10 ng of either pcDNA3.1+ (Invitrogen) or pcDNA-Tat was transfected into 293T cells using polyethylenimine (Polysciences) as previously described (Durocher et al., 2002) . Transfections were performed in 96 well plates seeded with 2×10 4 cells per well 24 h prior to transfection. Luciferase activity was measured 24 h post transfection with the Bright-Glo Luciferase Assay System (Promega) as per the manufacturer's instructions; 96 well plates were read in a Victor X3 plate luminometer (Perkin Elmer).
Viral strains
Plasmid pLAI, containing the complete HIV-1 LAI genome, was provided by Dr. Ben Berkhout (Peden et al., 1991) . The RBE1 (CAGCTGC to CAGggtg), and RBE3 (ACTGCTGA to ACTGCact) mutations were produced by PCR mediated site-directed mutagenesis using the oligonucleotides indicated in Table 2 , and then cloned into the unique XhoI and AatII restriction sites in the 3′ LTR of pLAI to create pLAI-mRBE1, pLAI-mRBE3, and pLAI-mRBE1/3. Similarly, mutations in the 5′ LTR of LAI were created by PCR mediated site-direct mutagenesis and cloned into the unique XbaI and BssHII sites. All mutations in the 3′ and 5′ LTRs were confirmed by DNA sequencing using the primers oMD099 and oMD105, respectively ( Table 2 ). The HIV-1 molecular clones used in this study are summarized in Table 3 . 
Virus production and infection assays
Wild type and mutant RBE viral stocks were produced by transfection of molecular clones into HEK 293T cells using polyethylenimine as previously described (Durocher et al., 2002) . The molecular clone used and amount transfected are indicated in the details of each experiment. HEK 239T cells were transfected in a 24 well plate seeded 24 h prior to transfection with 1.5 × 10 5 cells per well, except for the experiment in Fig. 6C where cells were transfected in a 96 well plate seeded with 2 × 10 4 cells per well. Viral supernatants were harvested 48 h post transfection, clarified by filtration (0.45 μm) and stored at − 80°C until use. HIV-1 p24 gag in the culture supernatant was quantified using a commercial ELISA kit as per the manufacturer's instructions (XpressBio). Proviral expression of the viruses was tested by infecting TZM-bl reporter cells and measuring production of β-galactosidase as previously described (Harari et al., 2009 ).
